Objectives

1. Identify patients at risk for non-polyposis colorectal cancer syndromes
2. Describe the genetic mutations responsible for Lynch Syndrome
3. Describe the phenotypic expression of Lynch I and Lynch II syndromes
4. Describe pathologic methods utilized to screen for microsatellite instability and Lynch syndrome
5. Describe the syndromes of hereditary non-polyposis colon cancer and Familial colorectal cancer X syndrome
6. Describe surveillance of Lynch syndrome patients and surgical options for those diagnosed with colorectal cancer
7. Describe chemoprevention strategies in patients with Lynch syndrome
8. Describe the role of immunotherapy in patients with Lynch syndrome

Faculty

Kirsten Bass Wilkins, MD
Clinical Assistant Professor of Surgery
UMDNJ - Robert Wood Johnson Medical School